Table 2.
Rates of MOUD prescription, retention in care, and acute care utilization in historical control and intervention groups
| Outcome | historical control group | intervention group | p-value |
|---|---|---|---|
| N | 90 | 113 | |
| 6-month any MOUD prescription | 63 (70.0%) | 110 (97.3%) | < 0.001 |
| 3-month treatment retention without care gap | 54 (60.0%) | 70 (61.9%) | 0.78 |
| 6-month treatment retention without care gap | 41 (45.6%) | 60 (53.1%) | 0.29 |
| 6-month all-cause hospitalization | a(1.1–11.1%) | a(0.9–8.8%) | 0.99 |
| 6-month emergency department utilization | 40 (44.4%) | 44 (38.9%) | 0.43 |
aCells containing a value of 1 to 10 or additional cells that allow the back calculation of those small cells were suppressed in accordance with Duke EHR cell suppression policy